Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans

DOI Web Site 被引用文献16件
  • Timothy M. Block
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Mary Ann Comunale
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Melissa Lowman
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Laura F. Steel
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Patrick R. Romano
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Claus Fimmel
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Bud C. Tennant
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • W. Thomas London
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Alison A. Evans
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Baruch S. Blumberg
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Raymond A. Dwek
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Tajinder S. Mattu
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom
  • Anand S. Mehta
    Drexel Institute for Biotechnology and Virology Research, Drexel University, Doylestown, PA 18901; Division of Gastroenterology, Saint Louis University School of Medicine, John Cochran Veterans Affairs Medical Center, St. Louis, MO 63106; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853; Fox Chase Cancer Center, Philadelphia, PA 19111; and Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom

書誌事項

公開日
2005-01-10
DOI
  • 10.1073/pnas.0408928102
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p>Chronic infection with hepatitis B virus (HBV) is associated with the majority of hepatocellular carcinoma (HCC). The diagnosis of HCC is usually made in the late stages of the disease, when treatment options are limited and prognosis is poor. We therefore have developed a method of glycoproteomic analysis in an attempt to discover serum markers that can assist in the early detection of HBV-induced liver cancer. Briefly, a comparative method for analysis of oligosaccharides released from serum glycoproteins and for recovery and identification of proteins with aberrant glycosylation, as a function of cancer diagnosis, is described. The model we have used is the woodchuck (<jats:italic>Marmota monax</jats:italic>), which shares similarities in the glycosylation pattern associated with liver proteins in human HCC. In this report, we show that woodchucks diagnosed with HCC have dramatically higher levels of serum-associated core α-1,6-linked fucose, as compared with woodchucks without a diagnosis of HCC. The coupling of this methodology with 2D gel proteomics has permitted the identification of several glycoproteins with altered glycosylation as a function of cancer. One such glycoprotein, Golgi Protein 73 (GP73), was found to be elevated and hyperfucosylated in animals with HCC. Further, the study showed GP73 to be elevated in the serum of people with a diagnosis of HCC, providing a validation of our approach. The potential of this technology for biomarker discovery and the implications of increased levels of GP73 in liver cancer are discussed.</jats:p>

収録刊行物

被引用文献 (16)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ